Previous 10 | Next 10 |
2024-01-26 10:08:35 ET Health Catalyst ( NASDAQ: HCAT ) was upgraded by analysts at Guggenheim, citing an improving macro-scenario that would boost technology demand and a better-than-expected operating leverage.... Read the full article on Seeking Alpha For further deta...
SacValley MedShare Selects Health Catalyst to Power its Qualified Health Information Organization (QHIO) PR Newswire SALT LAKE CITY , Jan. 8, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics te...
2023-12-12 11:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Health Catalyst's Analytics Solutions Save WakeMed Health & Hospitals $10 Million, Accelerates Clinical Transformation Health Catalyst's Analytics Solutions Save WakeMed Health & Hospitals $10 Million, Accelerates Clinical Transformation PR Newswire SALT LAKE CIT...
2023-11-22 15:23:00 ET More on Evolent Health, Health Catalyst, etc. Health Catalyst: After Q3 Earnings, I Continue To See This As A Buy Health Catalyst, Inc. (HCAT) Q3 2023 Earnings Call Transcript Omnicell, Inc. (OMCL) Q3 2023 Earnings Call Transcript Healt...
2023-11-14 08:26:12 ET Summary I reiterate a buy rating for HCAT stock due to its potential for growth acceleration and improved profitability. Management remains focused on profit improving initiatives. The stock has been derated, but if HCAT can improve margins, its valuatio...
2023-11-13 07:45:10 ET More on Health Catalyst Health Catalyst, Inc. (HCAT) Q3 2023 Earnings Call Transcript Health Catalyst Sees Growth In Tech-Enabled Managed Services Health Catalyst acquires cancer registry services provider Electronic Registry Systems He...
2023-11-05 12:00:34 ET More on Amwell, Teladoc Health, etc. American Well Corporation (AMWL) Q3 2023 Earnings Call Transcript Teladoc Q3 Earnings: Difficult Quarter, Tough Outlook, Slight Hopes Of A Turnaround Teladoc Health: Don't Fall For The Market's Profit Obsess...
2023-11-03 10:35:07 ET Health Catalyst, Inc. (HCAT) Q3 2023 Earnings Conference Call November 2, 2023 17:00 ET Company Participants Adam Brown - Investor Relations Dan Burton - Chief Executive Officer Bryan Hunt - Chief Financial Officer Conference Call Par...
Health Catalyst Inc (HCAT) is expected to report $-0.27 for Q3 2023
News, Short Squeeze, Breakout and More Instantly...
Health Catalyst Announces New Credit Facility for up to $225,000,000 PR Newswire SALT LAKE CITY , July 18, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst" or the "Company") (Nasdaq: HCAT), a leading provider of data and analytics technology and...
2024-07-01 07:30:03 ET Wells Fargo analyst issues OVERWEIGHT recommendation for HCAT on July 1, 2024 06:12AM ET. The previous analyst recommendation was Overweight. HCAT was trading at $6.39 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...